Pharmacy Report Archives - Page 5 of 150 - Becker's Hospital Review

18 top schools for pharmacology: US News | 3 areas hospitals are finding savings | FDA OKs 1st therapy to slow Type 1 diabetes | Menopause therapy prescribing jumps 4x | GLP-1s and male fertility: 4 notes

Plus: 10 CMS citations most likely to trigger immediate jeopardy June 17, 2026 1. 18 top US universities for pharmacology and toxicology: US News Full story 2. 3 areas health systems are hunting for non-labor savings Full story 3. Pharmacy…

Senate revives drug pricing push | Hospitals step in as chains shutter | Colo. wins FDA nod for Canada drug imports | States collect from CVS' $36.5M insulin settlement | Ill. sends $24M+ to 434 pharmacies

Plus: FDA imposes 5 compounded GLP-1 restrictions June 16, 2026 1. Health systems step in as pharmacy chains shutter Full story 2. Senate Democrats outline plans to lower drug prices: 4 notes Full story 3. Drug pricing pressure, 340B uncertainty,…

Texas Children's unlocks $14M in pharmacy savings | CMS moves to cement drug price talks | GLP-1s tied to $193K in lifetime healthcare savings | Cigna fights Tenn. PBM law | Cancer drug gets lifeline

Plus: Pharmacy chain to pay $40M to resolve allegations of inflated drug prices June 15, 2026 1. How Texas Children’s cut pharmacy inventory costs by $14M Full story 2. CMS floats permanent status for Medicare drug price negotiations: 5 things…

340B rebate fight escalates: 14 notes | Iowa flags $100M PBM payment model | 10 systems hiring pharmacy leaders | FDA adds kidney warning to weight loss drug | Drug costs strain Medicare trust fund

Plus: Lilly wins injunction in $200M fraud lawsuit June 11, 2026 1. The 340B rebate fight escalates: 14 key developments Full story 2. Iowa audit raises concerns about Medicaid PBM practices, cites $100M value Full story 3. Building the elite…

Health systems push to own specialty pharmacy | Next-gen GLP-1s target 3 key flaws | Drug shortages last longer than ever | 340B fight fails in Wash. | House votes to defund prior auth pilot

Plus: Drug overdose deaths fall in 42 states: 5 notes June 10, 2026 1. Drug shortages are lasting longer than ever: USP Full story 2. Next-gen GLP-1s target 3 key limitations: Report Full story 3. How do you prove pharmacy…

Pharmacy pay in '26: 5 notes | Lilly's 340B deadline passes: What to know | Feds win $3.4M pharmacy fraud case | Oral GLP-1 tops semaglutide | FDA OKs hemophilia B therapy for kids

Plus: New oral drug shows responses across 6 tumor types June 9, 2026 1. Pharmacy workforce compensation: What the numbers say in 2026 Full story 2. Eli Lilly’s 340B deadline passes: What hospitals should know Full story 3. The CPO…

TrumpRx expands to 800+ drugs | GLP-1s and cancer: 6 findings | AbbVie dealt 340B court loss | Drugmakers, patients push FDA to halt voucher plan | Breakthrough pancreatic cancer pill explained

Plus: 10 AI vendors gaining traction with health systems June 8, 2026 1. TrumpRx to expand coverage to more than 800 drugs Full story 2. GLP-1s and cancer: 6 things to know Full story 3. The 340B Rebate Reckoning is…

8 new drugs in shortage | New tariffs threaten hospital supply costs | 10 systems seeking pharmacy leaders | Novant launches pharmacy venture | SCOTUS clears path for generic drug 'skinny labels'

Plus: The promises and challenges of the FDA’s real-time clinical trial model June 4, 2026 1. 8 new drugs in shortage Full story 2. 10 systems seeking pharmacy leaders Full story 3. Karen McConnell at the University of Michigan. Elizabeth Oyekan at…

340B in 2026: What health systems need to know | Antibody-drug therapies raise serious infection alarms | 7 diseases GLP-1s may tackle next | ADHD drug hits FDA snag | Wis. hospital speeds up prescription delivery

Plus: 100 great community hospitals June 3, 2026 1. 340B in 2026: Tracking litigation, mandates and policy shifts reshaping the program Full story 2. 7 conditions GLP-1s may treat beyond weight loss Full story 3. NYU Langone + Henry Ford…

Lilly sets 5-day 340B ultimatum | AI medication monitoring flaw exposed after drug diversion | FDA OKs 1st oral COVID prevention pill | $300B patent cliff looms over hospital drug spend | GLP-1s tied to lower breast cancer risk

Plus: Demand surges for pancreatic cancer drug that outperforms chemo June 2, 2026 1. Eli Lilly gives hospitals 5 days to comply with 340B policy Full story 2. AI medication monitoring software flaw exposed after Tennessee Hospital drug diversion Full story…